antisense oligonucleotides

GPTKB entity

Properties (55)
Predicate Object
gptkbp:instanceOf oligonucleotide
gptkbp:canCreate nanoparticles
liposomes
gptkbp:designedFor bind complementary RNA
gptkbp:developedBy therapeutic applications
https://www.w3.org/2000/01/rdf-schema#label antisense oligonucleotides
gptkbp:involvedIn RNA interference
gptkbp:issuedBy injection
gptkbp:isUsedFor clinical trials
genetic disorders
personalized medicine
improve patient outcomes
cancer treatment
study gene function
viral infections
diagnostic applications
enhance therapeutic efficacy
identify biomarkers
develop new therapies
reduce side effects
improve delivery efficiency
validate drug targets
develop diagnostic tools
modulate gene expression
enhance vaccine efficacy
aid in drug development
alter splicing
analyze RNA structure
assess gene regulation
create RNA-based therapeutics
decrease toxicity
enhance RNA stability
evaluate therapeutic targets
examine RNA stability
facilitate functional genomics studies
increase specificity
inhibit translation
investigate RNA localization
investigate disease mechanisms
modulate miRNA activity
phosphorothioate chemistry
promote RNA degradation
reduce off-target effects
reduce protein expression
screen for drug candidates
study RNA-protein interactions
support gene therapy approaches
suppress mutant alleles
target disease-causing mutations
target non-coding RNAs
target specific isoforms
track RNA dynamics
gptkbp:producedBy chemical methods
gptkbp:targets gptkb:mRNA
gptkbp:usedFor gene silencing